Cargando…

Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass

OBJECTIVE: Infants are more vulnerable to kidney injuries induced by inflammatory response syndrome and ischemia-reperfusion injury following cardiopulmonary bypass especially with prolonged hypothermic low-flow (HLF). This study aims to evaluate the protective role of ulinastatin, an anti-inflammat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaocou, Xue, Qinghua, Yan, Fuxia, Liu, Jinping, Li, Shoujun, Hu, Shengshou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684368/
https://www.ncbi.nlm.nih.gov/pubmed/26656098
http://dx.doi.org/10.1371/journal.pone.0144516
_version_ 1782406179089022976
author Wang, Xiaocou
Xue, Qinghua
Yan, Fuxia
Liu, Jinping
Li, Shoujun
Hu, Shengshou
author_facet Wang, Xiaocou
Xue, Qinghua
Yan, Fuxia
Liu, Jinping
Li, Shoujun
Hu, Shengshou
author_sort Wang, Xiaocou
collection PubMed
description OBJECTIVE: Infants are more vulnerable to kidney injuries induced by inflammatory response syndrome and ischemia-reperfusion injury following cardiopulmonary bypass especially with prolonged hypothermic low-flow (HLF). This study aims to evaluate the protective role of ulinastatin, an anti-inflammatory agent, against acute kidney injuries in infant piglets model undergoing surgery on HLF cardiopulmonary bypass. METHODS: Eighteen general-type infant piglets were randomly separated into the ulinastatin group (Group U, n = 6), the control group (Group C, n = 6), and the sham operation group (Group S, n = 6), and anaesthetized. The groups U and C received following experimental procedure: median thoracotomy, routine CPB and HLF, and finally weaned from CPB. The group S only underwent sham median thoracotomy. Ulinastatin at a dose of 5,000 units/kg body weight and a certain volume of saline were administrated to animals of the groups U and C at the beginning of CPB and at aortic declamping, respectively. Venous blood samples were collected at 3 different time points: after anesthesia induction in all experimental groups, 5 minutes, and 120 minutes after CPB in the Groups U and C. Markers for inflammation and acute kidney injury were tested in the collected plasma. N-acetyl-β-D-glucosaminidase (NAG) from urine, markers of oxidative stress injury and TUNEL-positive cells in kidney tissues were also detected. RESULTS: The expressions of plasma inflammatory markers and acute kidney injury markers increased both in Group U and Group C at 5 min and 120 min after CPB. Also, numbers of TUNEL-positive cells and oxidative stress markers in kidney rose in both groups. At the time point of 120-min after CPB, compared with the Group C, some plasma inflammatory and acute kidney injury markers as well as TUNEL-positive cells and oxidative stress markers in kidney were significantly reduced in the Group U. Histologic analyses showed that HLF promoted acute tubular necrosis and dilatation. CONCLUSIONS: HLF cardiopulmonary bypass surgery could intensify systemic inflammatory responses and oxidative stress on infant piglets, thus causing acute kidney injury. Ulinastatin might reduce such inflammatory response and oxidative stress and the extent of kidney injury.
format Online
Article
Text
id pubmed-4684368
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46843682015-12-31 Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass Wang, Xiaocou Xue, Qinghua Yan, Fuxia Liu, Jinping Li, Shoujun Hu, Shengshou PLoS One Research Article OBJECTIVE: Infants are more vulnerable to kidney injuries induced by inflammatory response syndrome and ischemia-reperfusion injury following cardiopulmonary bypass especially with prolonged hypothermic low-flow (HLF). This study aims to evaluate the protective role of ulinastatin, an anti-inflammatory agent, against acute kidney injuries in infant piglets model undergoing surgery on HLF cardiopulmonary bypass. METHODS: Eighteen general-type infant piglets were randomly separated into the ulinastatin group (Group U, n = 6), the control group (Group C, n = 6), and the sham operation group (Group S, n = 6), and anaesthetized. The groups U and C received following experimental procedure: median thoracotomy, routine CPB and HLF, and finally weaned from CPB. The group S only underwent sham median thoracotomy. Ulinastatin at a dose of 5,000 units/kg body weight and a certain volume of saline were administrated to animals of the groups U and C at the beginning of CPB and at aortic declamping, respectively. Venous blood samples were collected at 3 different time points: after anesthesia induction in all experimental groups, 5 minutes, and 120 minutes after CPB in the Groups U and C. Markers for inflammation and acute kidney injury were tested in the collected plasma. N-acetyl-β-D-glucosaminidase (NAG) from urine, markers of oxidative stress injury and TUNEL-positive cells in kidney tissues were also detected. RESULTS: The expressions of plasma inflammatory markers and acute kidney injury markers increased both in Group U and Group C at 5 min and 120 min after CPB. Also, numbers of TUNEL-positive cells and oxidative stress markers in kidney rose in both groups. At the time point of 120-min after CPB, compared with the Group C, some plasma inflammatory and acute kidney injury markers as well as TUNEL-positive cells and oxidative stress markers in kidney were significantly reduced in the Group U. Histologic analyses showed that HLF promoted acute tubular necrosis and dilatation. CONCLUSIONS: HLF cardiopulmonary bypass surgery could intensify systemic inflammatory responses and oxidative stress on infant piglets, thus causing acute kidney injury. Ulinastatin might reduce such inflammatory response and oxidative stress and the extent of kidney injury. Public Library of Science 2015-12-14 /pmc/articles/PMC4684368/ /pubmed/26656098 http://dx.doi.org/10.1371/journal.pone.0144516 Text en © 2015 Wang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wang, Xiaocou
Xue, Qinghua
Yan, Fuxia
Liu, Jinping
Li, Shoujun
Hu, Shengshou
Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass
title Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass
title_full Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass
title_fullStr Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass
title_full_unstemmed Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass
title_short Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass
title_sort ulinastatin protects against acute kidney injury in infant piglets model undergoing surgery on hypothermic low-flow cardiopulmonary bypass
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684368/
https://www.ncbi.nlm.nih.gov/pubmed/26656098
http://dx.doi.org/10.1371/journal.pone.0144516
work_keys_str_mv AT wangxiaocou ulinastatinprotectsagainstacutekidneyinjuryininfantpigletsmodelundergoingsurgeryonhypothermiclowflowcardiopulmonarybypass
AT xueqinghua ulinastatinprotectsagainstacutekidneyinjuryininfantpigletsmodelundergoingsurgeryonhypothermiclowflowcardiopulmonarybypass
AT yanfuxia ulinastatinprotectsagainstacutekidneyinjuryininfantpigletsmodelundergoingsurgeryonhypothermiclowflowcardiopulmonarybypass
AT liujinping ulinastatinprotectsagainstacutekidneyinjuryininfantpigletsmodelundergoingsurgeryonhypothermiclowflowcardiopulmonarybypass
AT lishoujun ulinastatinprotectsagainstacutekidneyinjuryininfantpigletsmodelundergoingsurgeryonhypothermiclowflowcardiopulmonarybypass
AT hushengshou ulinastatinprotectsagainstacutekidneyinjuryininfantpigletsmodelundergoingsurgeryonhypothermiclowflowcardiopulmonarybypass